Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/1995
11/15/1995EP0681842A2 Ligand-mediated immunofunctional hormone binding protein assay method
11/15/1995EP0681585A1 Tata-binding protein associated factors, nucleic acids encoding tafs, and methods of use
11/15/1995EP0681484A1 Immunoreactive reagents employing heterodimers
11/15/1995EP0618930A4 Monoclonal antibody to hiv-2 and uses thereof.
11/15/1995EP0527977B1 Nematode vaccine
11/15/1995EP0448707B1 Bacteria harboring expression vectors encoding human CILIARY NEUROTROPHIC FACTOR (h-CNTF), their use in the production of h-CNTF, antibodies to h-CNTF and the use of h-CNTF in medical treatment
11/15/1995EP0431146B1 Radionuclide metal chelates for the radiolabeling of proteins
11/15/1995EP0420913B1 Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
11/15/1995CN1111910A Mammamodulin, a hormone-independent mammary tumor cells specific protein
11/14/1995US5466784 Monoclonal antibodies to salinomycin and method for detecting the same
11/14/1995US5466783 Human tissue factor inhibitor
11/14/1995US5466672 Anticancer
11/14/1995US5466671 Apidaecin-type peptide antibiotics with improved activities and/or different antibacterial spectrum
11/14/1995US5466610 Immunoassays for insulin sensitivity enhancers, insulin sensitivity enhancer antibodies, and non-thiazolidinedione insulin sensitivity enhancer compositions
11/14/1995US5466585 Interferon-induced human protein in pure form, monoclonal antibodies thereto, and test kits containing these antibodies
11/14/1995US5466377 Chromatography media and their uses
11/14/1995CA2123551A1 Methods and compositions for inhibiting killing of uninfected lymphocytes
11/10/1995CA2148898A1 P54 stress-activated protein kinases
11/09/1995WO1995030326A1 Neural receptor tyrosine kinase
11/09/1995WO1995030015A2 Isolated epstein-barr virus bzlf2 proteins that bind mhc class ii beta chains
11/09/1995WO1995030014A1 Bifunctional protein, preparation and use
11/09/1995WO1995030008A1 Density enhanced protein tyrosine phosphatases
11/09/1995WO1995030004A1 Monoclonal antibodies which promote central nervous system remyelination
11/09/1995WO1995029995A1 Wt1 monoclonal antibodies and methods of use therefor
11/09/1995WO1995029938A1 Antigen/antibody specificity exchanger
11/09/1995WO1995029699A1 Vaccine for, diagnostic assay for and method of treating parasitic hemoflagellate protozoa
11/09/1995WO1995029697A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
11/09/1995WO1995029693A1 Methods and compositions for modulating heterotypic e-cadherin interactions with t lymphocytes
11/09/1995WO1995029692A1 An advanced glycosylation endproduct-receptor, and diagnostic and therapeutic methods based thereon
11/09/1995WO1995029690A1 Biologically active peptides and methods of identifying the same
11/09/1995DE4415743A1 Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen Papillomaviruses means for their detection as well as for the treatment of diseases caused by them
11/09/1995CA2690298A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
11/09/1995CA2537374A1 Density enhanced protein tyrosine phosphatases
11/09/1995CA2188663A1 Wt1 monoclonal antibodies and methods of use therefor
11/09/1995CA2186365A1 Neural receptor tyrosine kinase
11/08/1995EP0681027A2 Plasmid vector and its use for the production of heterologous proteins
11/08/1995EP0680607A1 Assay method to rule out rupture of membranes in women at risk for imminent delivery
11/08/1995EP0680337A1 Methods and compositions for the direct concentrated delivery of passive immunity
11/08/1995EP0680336A1 Monoclonal anti-lfa-1 antibodies for the preparation of a medicament intended to prevent the rejection of organ transplants
11/08/1995EP0680334A1 Morphogen treatment of gastrointestinal ulcers
11/08/1995EP0680333A1 Prevention and treatment of cytomegalovirus using aminopeptidase
11/08/1995EP0680316A1 Novel parasitic helminth proteins
11/08/1995EP0419574B1 Monoclonal antibodies to the light chain region of human factor xii and methods of preparing and using the same
11/08/1995EP0393051B1 HUMAN ANTI-Rh(D) MONOCLONAL ANTIBODIES
11/08/1995CN1111157A Method and formulation for orally adminstering bioactive agents to and through the peyer's patch
11/07/1995US5464823 Mammalian antibiotic peptides
11/07/1995US5464822 Polypeptides and polypeptide analogues
11/07/1995US5464778 Glycoprotein ligand for P-selectin and methods of use thereof
11/07/1995US5464759 Sequential oligonucleotide syntheses using immunoaffinity techniques
11/07/1995US5464757 Corticotropin releasing factor, genetic engineering
11/07/1995US5464748 Method of detecting and monitoring levels of 3'-amino-3'-deoxythymidine in body fluids and antibodies for same
11/07/1995CA2063872C Pharmaceutical preparation based on plasma proteins
11/07/1995CA1337518C Monoclonal antibodies against tnf-–, hybridomas producing them and method for the purification of tnf-–
11/02/1995WO1995029404A1 Use of human neutrophil lipocalin (hnl) as a diagnostic marker and anti-hnl-antibody preparation
11/02/1995WO1995029239A2 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/02/1995WO1995029237A1 Cardiotrophin and uses therefor
11/02/1995WO1995029236A2 Lymphocyte activation antigens and antibodies thereto
11/02/1995WO1995029193A2 Melanoma antigens
11/02/1995WO1995029192A1 Thymidine kinase tk1, peptide, corresponding antibodies and use of these in determination of tumor proliferation
11/02/1995WO1995029188A1 Human sperm diagnostic
11/02/1995WO1995029180A1 Porphocyanine and cnc-expanded porphyrins
11/02/1995WO1995028962A1 Inhibition of myelin destruction by interfering with the interaction between mac-2 and myelin
11/02/1995WO1995028961A1 Remedy for rheumatoid arthritis
11/02/1995WO1995028957A2 Methods for inducing t cell tolerance to a tissue or organ graft
11/02/1995WO1995028946A1 Methods and compositions for inhibiting endothelial cell and fibrinogen mediated inflammation
11/02/1995EP0679717A2 Soluble interferon -receptor, its preparation and use
11/02/1995EP0679660A1 Antihuman tyrosinase monoclonal antibody
11/02/1995EP0679186A1 Monokine mig induced by ifn-gamma
11/02/1995EP0679163A1 Growth differentiation factor-3
11/02/1995EP0679094A1 Compounds for targeting
11/02/1995EP0679083A1 Prevention and treatment of sepsis
11/02/1995DE4414787A1 Analysis and detection of tumours using variable CD44 exons,
11/02/1995CA2722364A1 Melanoma antigens
11/02/1995CA2188672A1 Methods for inducing t cell tolerance to a tissue or organ graft
11/02/1995CA2188543A1 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/02/1995CA2188397A1 Human sperm diagnostic
10/1995
10/31/1995US5463028 Compound comprising a methyl ecgonine group chemically attached to a phenylphosphonic group which is an analog to an intermediate of the hydrolysis transition-state of a cocaine benzoyl ester group
10/31/1995US5463026 Anti-human prohibitin antibodies
10/31/1995US5462925 Transforming growth factor β2,3
10/31/1995US5462871 Nonapeptides bind to human leukocyte antigens on cell surfaces leading to lysis by cytolytic T lymphocytes
10/31/1995US5462853 Contacting samples with lectin to form specific binding complexes between the lectin and components of the sample, determining amount of the complexes, and correlating this amount to the amount of the components in the sample
10/31/1995US5462852 Contacting lysate of biological sample with detectable amount of antibody specifically reactive with p7 antigen or fragment for time and under conditions for forming antigen-antibody complex, determining presence of complex to indicate infection
10/30/1995CA2122874A1 Neural receptor tyrosine kinase
10/26/1995WO1995028644A1 Method for the immuno-assay of antithrombin iii activated by a glycosaminoglycan, corresponding monoclonal antibodies and method for producing them
10/26/1995WO1995028642A1 A method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein
10/26/1995WO1995028499A1 Nucleic acid encoding transcription factor p300 and uses of p300
10/26/1995WO1995028484A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995WO1995028483A1 Cell-cycle regulatory proteins, and uses related thereto
10/26/1995WO1995028478A1 Rps2 gene and uses thereof
10/26/1995WO1995028474A1 Dna encoding bradykinin b1 receptor
10/26/1995WO1995028423A1 Rps gene family, primers, probes, and detection methods
10/26/1995WO1995028411A1 Sequence encoding mammalian sulfonylurea receptor and method of detecting persistent hyperinsulinemic hypoglycemia of infancy
10/26/1995WO1995028176A1 Method of treating hiv infection using antibodies against cytotoxic t-cells and thymic humoral factor
10/26/1995WO1995028172A1 Human bone stimulating factor
10/26/1995WO1995028169A1 Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression and cancer treatment
10/26/1995DE4447484A1 APO-1 inhibitor compsn. inhibits apoptosis
10/26/1995CA2189028A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995CA2188172A1 Human bone stimulating factor
10/26/1995CA2187945A1 Sequence encoding mammalian sulfonylurea receptor and method of detecting persistent hyperinsulinemic hypoglycemia of infancy
10/26/1995CA2187779A1 A method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein
1 ... 1348 1349 1350 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 ... 1494